South Korean health authorities have found more evidence that people who tested positive for Covid-19 again after being given the all-clear have not been reinfected.
Last month, dozens of patients who had recovered from the illness later tested positive again.
Doctors worried that some people who survived Covid-19 could become sick with it a second time, complicating efforts to lift quarantine restrictions and produce a vaccine.
But after weeks of research, they now say that such test results appear to be "false positives" caused by lingering, but probably not infectious, bits of the virus.
South Korea reported more than 350 such cases as of Wednesday, the Korea Centres for Disease Control and Prevention said.
What is happening?
As more and more South Koreans were released from treatment for Covid-19, authorities discovered a disturbing trend. Some ostensibly cured patients were later testing positive.
While officials examined several possible explanations, including reinfection of patients or reactivation of the virus, an expert panel convened by the government concluded last week that the most likely explanation was that the tests were returning false positives.
South Korea uses reverse transcription-polymerase chain reaction tests, which detect the coronavirus's genetic material.
The process can quickly return results and is considered the most accurate way to find out if a patient is infected.
But in some cases, the tests may detect old particles of the virus, which may no longer pose a significant threat to the patient or others, said Seol Dai-wu, an expert in vaccine development at Seoul's Chung-Ang University.
"The machine cannot distinguish an infectious viral particle versus a non-infectious virus particle, as the test simply detects any viral component," Mr Seol said.
This false-positive result is probably behind the cases of recovered patients testing positive again, the Korean centre says.
Authorities are still gathering evidence to support their theory that the particles are from "dead" virus cells, centre director Jeong Eun-kyeong said on Wednesday.
The patients were retested after they exhibited new respiratory symptoms or were selected by authorities.
Less than half of those retested by mid-April were showing symptoms, the centre said.
But authorities now say it is unlikely that those symptoms were caused by the coronavirus.
Are the patients still infectious?
Patients who tested positive for the new coronavirus after recovering from Covid-19 do not appear to be infectious.
The centre has not found one case where such patients passed the coronavirus to another person, Ms Jeong said.
When investigating people who appear to suffer a relapse of symptoms after recovering, the centre takes cultures of the virus, which takes more than two weeks before reliable results become evident.
All 29 completed culture tests as of Wednesday had come back negative. At least 79 are being processed.
"The virus in the relapse cases have little to no infectiousness," Ms Jeong said.
Oh Myoung-don, a doctor at Seoul National University Hospital who is leading the panel of experts investigating the cases, said unlike hepatitis B or HIV, coronavirus does not infiltrate the host cell's nucleus.
That means it does not cause chronic infection and chances of it reactivating are very low, Dr Oh said at a briefing last week.
Authorities are also conducting tests to detect the presence of antibodies that may have developed to fight the virus.
They are testing and monitoring people who came into contact with the patients.
COMPANY%20PROFILE
%3Cp%3E%3Cstrong%3ECompany%20name%3C%2Fstrong%3E%3A%20ASI%20(formerly%20DigestAI)%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EStarted%3A%3C%2Fstrong%3E%202017%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EFounders%3A%3C%2Fstrong%3E%20Quddus%20Pativada%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EBased%3A%3C%2Fstrong%3E%20Dubai%2C%20UAE%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EIndustry%3A%3C%2Fstrong%3E%20Artificial%20intelligence%2C%20education%20technology%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EFunding%3A%3C%2Fstrong%3E%20%243%20million-plus%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EInvestors%3A%3C%2Fstrong%3E%20GSV%20Ventures%2C%20Character%2C%20Mark%20Cuban%3C%2Fp%3E%0A
Mercer, the investment consulting arm of US services company Marsh & McLennan, expects its wealth division to at least double its assets under management (AUM) in the Middle East as wealth in the region continues to grow despite economic headwinds, a company official said.
Mercer Wealth, which globally has $160 billion in AUM, plans to boost its AUM in the region to $2-$3bn in the next 2-3 years from the present $1bn, said Yasir AbuShaban, a Dubai-based principal with Mercer Wealth.
“Within the next two to three years, we are looking at reaching $2 to $3 billion as a conservative estimate and we do see an opportunity to do so,” said Mr AbuShaban.
Mercer does not directly make investments, but allocates clients’ money they have discretion to, to professional asset managers. They also provide advice to clients.
“We have buying power. We can negotiate on their (client’s) behalf with asset managers to provide them lower fees than they otherwise would have to get on their own,” he added.
Mercer Wealth’s clients include sovereign wealth funds, family offices, and insurance companies among others.
From its office in Dubai, Mercer also looks after Africa, India and Turkey, where they also see opportunity for growth.
Wealth creation in Middle East and Africa (MEA) grew 8.5 per cent to $8.1 trillion last year from $7.5tn in 2015, higher than last year’s global average of 6 per cent and the second-highest growth in a region after Asia-Pacific which grew 9.9 per cent, according to consultancy Boston Consulting Group (BCG). In the region, where wealth grew just 1.9 per cent in 2015 compared with 2014, a pickup in oil prices has helped in wealth generation.
BCG is forecasting MEA wealth will rise to $12tn by 2021, growing at an annual average of 8 per cent.
Drivers of wealth generation in the region will be split evenly between new wealth creation and growth of performance of existing assets, according to BCG.
Another general trend in the region is clients’ looking for a comprehensive approach to investing, according to Mr AbuShaban.
“Institutional investors or some of the families are seeing a slowdown in the available capital they have to invest and in that sense they are looking at optimizing the way they manage their portfolios and making sure they are not investing haphazardly and different parts of their investment are working together,” said Mr AbuShaban.
Some clients also have a higher appetite for risk, given the low interest-rate environment that does not provide enough yield for some institutional investors. These clients are keen to invest in illiquid assets, such as private equity and infrastructure.
“What we have seen is a desire for higher returns in what has been a low-return environment specifically in various fixed income or bonds,” he said.
“In this environment, we have seen a de facto increase in the risk that clients are taking in things like illiquid investments, private equity investments, infrastructure and private debt, those kind of investments were higher illiquidity results in incrementally higher returns.”
The Abu Dhabi Investment Authority, one of the largest sovereign wealth funds, said in its 2016 report that has gradually increased its exposure in direct private equity and private credit transactions, mainly in Asian markets and especially in China and India. The authority’s private equity department focused on structured equities owing to “their defensive characteristics.”
Killing of Qassem Suleimani
Sarfira
Director: Sudha Kongara Prasad
Starring: Akshay Kumar, Radhika Madan, Paresh Rawal
Rating: 2/5
The specs: 2018 Kia Picanto
Price: From Dh39,500
Engine: 1.2L inline four-cylinder
Transmission: Four-speed auto
Power: 86hp @ 6,000rpm
Torque: 122Nm @ 4,000rpm
Fuel economy, combined: 6.0L / 100km
SCORES IN BRIEF
New Zealand 153 and 56 for 1 in 22.4 overs at close
Pakistan 227
(Babar 62, Asad 43, Boult 4-54, De Grandhomme 2-30, Patel 2-64)
COMPANY%20PROFILE%20
%3Cp%3EName%3A%20DarDoc%3Cbr%3EBased%3A%20Abu%20Dhabi%3Cbr%3EFounders%3A%20Samer%20Masri%2C%20Keswin%20Suresh%3Cbr%3ESector%3A%20HealthTech%3Cbr%3ETotal%20funding%3A%20%24800%2C000%3Cbr%3EInvestors%3A%20Flat6Labs%2C%20angel%20investors%20%2B%20Incubated%20by%20Hub71%2C%20Abu%20Dhabi's%20Department%20of%20Health%3Cbr%3ENumber%20of%20employees%3A%2010%3C%2Fp%3E%0A
Springsteen: Deliver Me from Nowhere
Director: Scott Cooper
Starring: Jeremy Allen White, Odessa Young, Jeremy Strong
Rating: 4/5
MATCH INFO
Uefa Champions League, Group C
Liverpool v Red Star Belgrade
Anfield, Liverpool
Wednesday, 11pm (UAE)